GENEVA/LONDON, Feb 3 – India’s Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the U.N. Children’s Fund said on Wednesday.
Read more here:: ZA Local News
